Market revenue in 2023 | USD 39.6 million |
Market revenue in 2030 | USD 61.6 million |
Growth rate | 6.5% (CAGR from 2023 to 2030) |
Largest segment | Meibomian gland expression (mgx) |
Fastest growing segment | Broadband light (BBL) |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Broadband light (BBL), Intense Pulsed Light (IPL), Meibomian Gland Expression (MGX), Combination (MGX+IPL) |
Key market players worldwide | Sight Sciences Inc, Lumenis, Johnson & Johnson, Alcon Inc, MiBo Medical Group, ESW vision |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dry eye treatment devices market will help companies and investors design strategic landscapes.
Meibomian gland expression (mgx) was the largest segment with a revenue share of 41.67% in 2023. Horizon Databook has segmented the Latin America dry eye treatment devices market based on broadband light (bbl), intense pulsed light (ipl), meibomian gland expression (mgx), combination (mgx+ipl) covering the revenue growth of each sub-segment from 2018 to 2030.
The penetration of dry eye treatment devices in Latin America is gradually increasing, due to the growing prevalence of DED in Brazil and Mexico. Presence of fewer competitors and high demand for treatments make it an attractive region for global players as well as new entrants. Several global players are looking to distribute technologically advanced dry eye treatment devices in the region.
Farbac Biomedical, SA offers ophthalmologic services in Mexico through its surgical and medical devices. The company offers the E-Eye device by ESW Vision to ophthalmologists in Mexico for enhanced dry eye treatment. Similarly, Lumenis provides the M22 Optima IPL for treating dry eye in Brazil. Therefore, growing adoption technologies, such as IPL, for treating dry eye is expected to drive the overall market in Latin America.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America dry eye treatment devices market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America dry eye treatment devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account